Formula
Listing Methodology Guide
Last updated: 19 April 2026
Use this guide to understand how Formula thinks about normalized naming, offer quality, merchant support, and procurement risk.
What to review
- Formula separates search relevance from merchant support and documentation quality.
- Availability, shipping support, and checkout behavior are distinct signals and should not be collapsed into one score.
- Market-specific pages help interpret the same compound differently in the US, Canada, Germany, France, and the UK.
Related compound pages
Compound page
Retatrutide
Retatrutide draws high search interest and elevated regulatory sensitivity. Formula handles this page with especially strict research-use framing and avoids therapeutic or consumer-outcome positioning.
Compound page
Tirzepatide
Tirzepatide remains a highly searched research compound with strong supplier and region intent. Formula keeps this page strictly documentation-led because signal quality and compliance sensitivity are both high.
Compound page
Semaglutide
Semaglutide is a high-interest research compound whose listings require especially careful separation of catalog data from unsupported consumer outcomes. Formula treats it as a documentation-first page.